Layla Zulfa
Taiwan has officially entered a transformative and challenging demographic era, transitioning into what is internationally recognized as a super-aged society. With more than 20% of its population now aged 65 or older, the nation faces an unprecedented surge in demand for medical services, driven by a rise in chronic diseases, age-related disabilities, infectious threats, and complex cancers. This demographic shift has placed the National Health Insurance (NHI) system under immense strain, prompting experts and policy committees to call for a fundamental paradigm shift in how the state manages public health. While Taiwan has historically earned global acclaim for its healthcare accessibility and treatment capacity, current policy frameworks remain heavily skewed toward downstream care—treating illness after it occurs—rather than proactive, upstream intervention.
To realize the "Healthy Taiwan" vision championed by the administration of President Lai Ching-te, a strategic overhaul is required. The Committee on Healthcare Policy has recommended that the government move toward a model centered on prevention, early intervention, precision care, and digital innovation. By aligning fragmented chronic disease programs, addressing gaps in early-stage cognitive care, and leveraging data-driven tools, Taiwan aims to strengthen its healthcare resilience and contain the escalating long-term costs associated with an aging citizenry.
The Evolution of Taiwan’s Healthcare Challenge: A Chronological Context
The journey toward this demographic milestone has been decades in the making. In 1993, Taiwan became an "aged society" when those over 65 reached 7% of the population. By 2018, that figure doubled to 14%. The arrival of 2025 marks the "super-aged" threshold of 20%, a pace of aging that is among the fastest in the world, surpassing many Western nations.
In response to these trends, the government launched the "Long-Term Care 2.0" program in 2017 to expand community-based services. However, as the burden of chronic illness grew, it became clear that social care alone was insufficient without a robust medical counterpart. This led to the proposal of the "888 Plan," a flagship initiative of the current administration designed to ensure that 80% of patients with chronic diseases receive regular monitoring, 80% of those monitored achieve blood pressure and glucose control, and 80% of the high-risk population receives lifestyle interventions. Despite these goals, the healthcare system remains fragmented, necessitating the more integrated approach currently being advocated by policy experts.
Strengthening Chronic Disease Governance Through Precision Care
Chronic diseases, particularly diabetes and chronic kidney disease (CKD), are the primary drivers of healthcare utilization in Taiwan. According to data from the National Health Insurance Administration (NHIA), these two conditions alone account for an annual expenditure exceeding NT$100 billion. As the population ages, these costs are projected to spiral unless a "precision care" model is adopted.
The Committee’s recommendations highlight a critical flaw in the current system: management approaches often fail to differentiate patients based on individual risk levels. This lack of stratification leads to delayed interventions for high-risk individuals, such as those with poor glycemic control or early signs of renal impairment. To rectify this, the Committee suggests strengthening risk stratification within existing frameworks and facilitating earlier referrals to specialized care networks.
Furthermore, there is a call for the establishment of a "National Chronic Disease Cross-Sector Alliance." This body would coordinate efforts between medical centers, regional hospitals, and primary care providers, ensuring that clinical protocols and data are shared seamlessly. A significant hurdle remains the misalignment of incentives; for instance, reimbursement points for early-stage CKD are currently lower than those for metabolic syndrome, which discourages medical institutions from early enrollment. Aligning these financial incentives with preventive outcomes is seen as essential for reducing the current average of eight "unhealthy years" that Taiwanese citizens experience at the end of their lives.
Addressing the "Silent Epidemic" of Obesity and Fatty Liver
The Executive Yuan recently announced that "Healthy Taiwan" will prioritize obesity and fatty liver care, recognizing them as the "upstream" triggers for more severe chronic conditions. The Committee recommends drawing on international benchmarks, such as South Korea’s NHI model, to integrate Body Mass Index (BMI) monitoring into standardized care under the 888 Program.
By prioritizing overweight and obese populations for longitudinal management—including both lifestyle and pharmacological interventions—Taiwan can mitigate the risk of cardio-renal deterioration. This strategy also extends to pediatric care, with a focus on family-centered interventions to prevent the onset of chronic diseases in the next generation, thereby bolstering long-term system resilience.
Early Intervention: Preventing Disability and Extending Healthy Life
In a super-aged society, simply expanding long-term care capacity is a reactive strategy that cannot keep pace with demand. Data from the Health Promotion Administration (HPA) indicates that approximately 30% of Taiwanese citizens aged 65 and above are already at risk of frailty or disability. The Committee argues for a shift in policy toward identifying and intervening at the "pre-disability" stage.
A primary focus of this shift is dementia and brain health. Current frameworks are largely reactive, focusing on moderate to severe stages of cognitive decline. However, with the emergence of disease-modifying therapies and biomarker-based diagnostics—such as blood-based screenings and PET scans—there is an opportunity to intervene during mild cognitive impairment (MCI). Repositioning policy toward early-stage brain health management could significantly slow disease progression and reduce the future burden on the long-term care system.
Additionally, the Committee suggests a tighter integration between post-acute care and long-term care for stroke and neurodegenerative disease patients. By introducing integrated care models supported by dedicated case managers, the system can ensure that patients adhere to rehabilitation and risk-factor control, thereby preserving their functional independence for longer periods.
Immunization as a Pillar of Healthcare Resilience
Vaccination is often overlooked as a tool for economic and systemic stability, yet it remains one of the most cost-effective public health interventions. In Taiwan, adult vaccination rates remain suboptimal. Influenza coverage among the elderly stands at approximately 50%, while pneumococcal vaccination rates are below 40%.
The Committee proposes that vaccination be embedded directly into chronic disease management workflows. For example, the Family Physician Program could include pneumococcal and COVID-19 vaccination status as key performance indicators. To support this, the government is encouraged to ensure the sustainability of the National Vaccine Fund. While the public budget contribution to the fund reached 76% this year, stable and predictable funding is required to incorporate new, innovative vaccines into the national schedule.
Furthermore, the Committee suggests a reform of the regulatory process for vaccine lot release. Currently, Taiwan employs a rigorous batch-by-batch testing system. Adopting a more risk-based, tiered approach—similar to practices in the EU or A10 countries—could improve efficiency and ensure that life-saving vaccines reach the public more quickly without compromising safety standards.
Digital Innovation: Scaling the "Health Coin" Ecosystem
To transition toward a "contactless" and smart healthcare model, Taiwan is looking to scale its digital health initiatives. The "Health Coin" program, which rewards citizens with digital incentives for participating in screenings and vaccinations, provides a foundation for a broader digital health ecosystem.
The Committee recommends expanding this program to include high-frequency preventive behaviors, such as daily physical activity and weight management, verified through wearable devices. By integrating this data into the "My Health Bank" platform, the government can create a more comprehensive picture of population health.
Public-private collaboration is viewed as a key driver here. By allowing private sector partners—such as the fitness and nutrition industries—to access de-identified health achievement signals, the government can foster a wellness economy that supports national health objectives. This digital push also includes the advancement of telehealth, particularly for remote areas, ensuring that consultation, prescription, and pharmaceutical logistics are integrated into a seamless, data-driven model.
A Comprehensive Framework for Cancer Control
Cancer has been the leading cause of death in Taiwan for over 40 years. While the government aims to reduce cancer mortality by one-third, achieving this goal requires more than just clinical excellence; it requires a structural overhaul of screening and financing.
Currently, screening participation for breast and colorectal cancer remains below 40%. The Committee recommends adopting risk-based screening strategies and addressing urban-rural disparities through mobile health services. On the treatment side, there is a push to optimize reimbursement for Next-Generation Sequencing (NGS) to align with international precision medicine standards.
Perhaps most critically, the Committee calls for the institutionalization and expansion of the Cancer Drugs Fund to a level of NT$10 billion. This fund is essential for providing timely access to innovative therapies that might otherwise be delayed by the NHI’s strict budget controls. Establishing a clear legal framework and a predictable transition for these drugs into the permanent NHI system will be vital for maintaining continuity of care for cancer patients.
Implications and Future Outlook
The recommendations put forth by the Committee represent a comprehensive roadmap for navigating the "silver tsunami." The shift from a volume-based treatment model to a value-based prevention model is not merely a medical necessity but a fiscal one. As the working-age population shrinks, the economic sustainability of the NHI depends on the ability to keep the elderly population healthy, active, and independent for as long as possible.
Industry analysts suggest that if these reforms are successfully implemented, Taiwan could serve as a global blueprint for other nations facing similar demographic declines. The integration of high-tech digital tools with a robust primary care network offers a pathway to a "Healthy Taiwan" that is resilient, innovative, and equitable. However, the success of this vision will depend on the government’s ability to break down ministerial silos and foster a truly cross-sectoral approach to public health governance.
Lina Irawan
Jia Lissa
